This content is machine translated Diabetic nephropathy Inhibition of sodium-glucose transporter type 2 has a renoprotective effect Diabetic nephropathy is the most common cause of chronic kidney failure – and one of the most common consequences of diabetes mellitus. The introduction of sodium-glucose transporter type 2 (SGLT2)…
View Post 4 min This content is machine translated Renal failure SGLT-2 inhibitors: a breakthrough in nephroprotection? Research into treatments for chronic kidney disease has stagnated for a long time. Now there is good news. SGLT2 inhibitors and GLP-1 are promising hopefuls, as recent findings show.
View Post 5 min This content is machine translated Nephrology There are many myths about it In renal healthy individuals, adequate drinking may reduce the risk of renal dysfunction. In chronic renal failure, the effects of fluid intake depend, among other things, on the stage of…
View Post 10 min This content is machine translated Type 2 diabetes Focus Heart & Kidney: Update on the 2019 ESC and ERA-EDTA Guidelines. Type 2 diabetes is associated with an increased risk of both cardiovascular events and the development of chronic kidney disease. These aspects are therefore increasingly finding their way into current…
View Post 2 min This content is machine translated Chronic kidney disease Effective blood pressure reduction helps prevent CKD Chronic kidney disease is a progressive disease closely associated with hypertension. In a large number of patients requiring renal replacement therapy, consistent blood pressure reduction could have prevented end-stage renal…
View Post 6 min This content is machine translated Nephrology Kidney and analgesics – recommendations for practice Pain management in patients with severe chronic kidney disease is no trivial matter due to limiting factors. Not only potential side effects can make the use of the painkillers also…
View Post 3 min This content is machine translated Hypertension and kidney disease Antihypertensives can prevent renal replacement therapy In a significant proportion of patients with kidney disease requiring dialysis, high blood pressure is a major factor in the advanced stage of the disease. Antihypertensive therapy may reduce the…
View Post 7 min This content is machine translated Chronic renal failure Nephroprotection – progress at last! Nephroprotection includes interventions that slow GFR decline over time, thereby delaying end-stage renal failure. The most recent intervention is the use of SGLT2 inhibitors in patients with diabetic nephropathy.
View Post 5 min This content is machine translated Type 2 diabetes: SGED recommendations update Reduction of cardiovascular complications as top priority Prevention of microvascular and macrovascular complications is an important overarching goal in the management of type 2 diabetes, and the current SGED guidelines have further informed decision making in cardiovascular…
View Post 2 min This content is machine translated Iron deficiency Effective management of a cardio-renal patient. Heart failure often does not come alone. One third of the patients also suffer from renal insufficiency. A major challenge here is the iron deficiency that often occurs. Interdisciplinary management…
View Post 4 min This content is machine translated Checkpoint Inhibitors Urothelial carcinoma of the urinary bladder – system therapy in transition Checkpoint inhibitors have now become established as a new therapeutic standard in the second-line treatment of metastatic urothelial carcinoma. However, its use could also be useful in first-line therapy.
